EMEvelyn M. Molloy

Evelyn M. Molloy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Evelyn M. Molloy has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Hertweck

    Department of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Leibniz-HKI), Jena, Germany

    20 shared publications
  • Kyle L. Dunbar

    Department of Biomolecular Chemistry Leibniz Institute for Natural Product Research and Infection Biology (HKI) Beutenbergstr. 11a 07745 Jena Germany

    11 shared publications
  • Maria Dell

    Department of Biomolecular Chemistry Leibniz Institute for Natural Product Research and Infection Biology (HKI) 07745 Jena Germany

    9 shared publications
  • Kirstin Scherlach

    Dept. of Biomolecular Chemistry Leibniz Institute for Natural Product Research and Infection Biology Jena Germany

    6 shared publications
  • Therese Horch

    Research Unit Biomolecular Chemistry Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute Adolf-Reichwein-Straße 23 07745 Jena Germany

    6 shared publications
  • Jana Kumpfmüller

    Dept. of Biomolecular Chemistry Leibniz Institute for Natural, Product Research and Infection Biology HKI Beutenbergstr. 11a 07745 Jena Germany

    5 shared publications

Latest Publications

  • Open Access

    Structural and Functional Siderophore Remodeling by Enzymatic Delipidation

    by Elena Herzog, Keishi Ishida, Evelyn M. Molloy, Ron Hermenau, Kirstin Scherlach, Christian Hertweck

    Bacteria employ specialized metabolites called siderophores to acquire scarce iron, but these molecules may serve additional ecological roles. Here, we reveal that Pandoraea species, including environmental isolates and opportunistic pathogens typically acquired from the environment, produce bifunctional lipopeptides that undergo enzymatic remodeling to switch from promoting bacterial motility to optimizing iron capture. Through genome mining and metabolic profiling, we discovered pandorachelins, diazeniumdiolate‐containing siderophores. Comprehensive NMR analysis, derivatization, and isotope labeling established that pandorachelin A is a head‐to‐tail‐fused homodetic cyclopeptide, revising a recently proposed structure. We identified the elusive biosynthetic precursor, pandorachelin B, as a lipocyclopeptide with a lactone moiety and N‐terminal fatty acid. A specialized acylase (PdnM) cleaves the lipid tail of pandorachelin B, triggering an O→N acyl shift that contracts the ring and transforms the biological function: the lipopeptide enables bacterial swarming through surfactant activity, while the delipidated product exhibits enhanced iron‐chelating capacity but no motility promotion. Genetic knockouts, enzyme reconstitution, and phenotypic assays confirm this maturation sequence. The functional switch correlates with ecological niche across Pandoraea species, revealing a sophisticated strategy for niche colonization and nutrient acquisition. These findings identify PdnM as a potential antivirulence target and expand the functional repertoire of bacterial siderophores.

  • Open Access

    Structural and Functional Siderophore Remodeling by Enzymatic Delipidation

    by Elena Herzog, Keishi Ishida, Evelyn M. Molloy, Ron Hermenau, Kirstin Scherlach, Christian Hertweck

    Bacteria employ specialized metabolites called siderophores to acquire scarce iron, but these molecules may serve additional ecological roles. Here, we reveal that Pandoraea species, including environmental isolates and opportunistic pathogens typically acquired from the environment, produce bifunctional lipopeptides that undergo enzymatic remodeling to switch from promoting bacterial motility to optimizing iron capture. Through genome mining and metabolic profiling, we discovered pandorachelins, diazeniumdiolate‐containing siderophores. Comprehensive NMR analysis, derivatization, and isotope labeling established that pandorachelin A is a head‐to‐tail‐fused homodetic cyclopeptide, revising a recently proposed structure. We identified the elusive biosynthetic precursor, pandorachelin B, as a lipocyclopeptide with a lactone moiety and N‐terminal fatty acid. A specialized acylase (PdnM) cleaves the lipid tail of pandorachelin B, triggering an O→N acyl shift that contracts the ring and transforms the biological function: the lipopeptide enables bacterial swarming through surfactant activity, while the delipidated product exhibits enhanced iron‐chelating capacity but no motility promotion. Genetic knockouts, enzyme reconstitution, and phenotypic assays confirm this maturation sequence. The functional switch correlates with ecological niche across Pandoraea species, revealing a sophisticated strategy for niche colonization and nutrient acquisition. These findings identify PdnM as a potential antivirulence target and expand the functional repertoire of bacterial siderophores.

  • Open Access

    Dual-use virulence factors of the opportunistic pathogen Chromobacterium haemolyticum mediate hemolysis and colonization

    by Leo Dumjahn, Philipp Wein, Evelyn M. Molloy, Kirstin Scherlach, Felix Trottmann, Philippe R. Meisinger, Louise M. Judd, Sacha J. Pidot, Timothy P. Stinear, Ingrid Richter, et al.

    Chromobacterium haemolyticum is an environmental bacterium that can cause severe and fatal opportunistic infections in humans and animals. Although C. haemolyticum is characterized by its strong β-hemolytic activity, the molecular basis of this phenotype has remained elusive over the more than 15 years since the species was first described. Herein, we report a family of cyclic lipodepsipeptides, the jagaricins, that are responsible for the potent hemolytic activity of C. haemolyticum . Comparative genomics of C. haemolyticum strains revealed a completely conserved gene locus ( hml ) encoding a nonribosomal peptide synthetase. Metabolic profiling of C. haemolyticum DSM 19808 identified a suite of cyclic lipodepsipeptides as the products, with the three main congeners (jagaricin A–C) being elucidated by a combination of tandem mass spectrometry, chemical derivatization, and nuclear magnetic resonance spectroscopy. Significantly, a C. haemolyticum hml deletion mutant is devoid of hemolytic activity. Moreover, purified jagaricins are hemolytic at low micromolar concentrations in an erythrocyte lysis assay. Further bioassays demonstrated that the cyclic lipodepsipeptides are crucial for the biofilm-forming and swarming behavior of C. haemolyticum . Matrix-assisted laser desorption ionization mass spectrometry imaging showed that primarily jagaricin B and C are involved in these processes in vitro . Our data shed light on the bioactivities of jagaricins, specialized metabolites that likely contribute to both successful niche colonization and the virulence potential of C. haemolyticum . IMPORTANCE: Despite the rising incidence of Chromobacterium haemolyticum as a serious opportunistic pathogen, there is limited information on whether the competitive traits that ensure its survival in its freshwater niche also influence host infection. We reveal that C. haemolyticum produces specialized metabolites that not only cause its pronounced hemolytic phenotype but are also crucial for biofilm formation and swarming motility. These results exemplify a case of coincidental evolution, wherein the selective pressures encountered in a primary environmental niche drive the evolution of a trait impacting virulence. This knowledge provides a foundation for the development of antivirulence therapies against the emerging pathogen C. haemolyticum .


  • Open Access

    Dual-use virulence factors of the opportunistic pathogen Chromobacterium haemolyticum mediate haemolysis and colonization

    by Leo Dumjahn, Philipp Wein, Evelyn M. Molloy, Kirstin Scherlach, Felix Trottmann, Philippe Meisinger, Louise M. Judd, Sacha J. Pidot, Timothy P. Stinear, Ingrid Richter, et al.

    Chromobacterium haemolyticum is an environmental bacterium that can cause severe and fatal opportunistic infections in humans and animals. Although C. haemolyticum is characterized by its strong β-haemolytic activity, the molecular basis of this phenotype has remained elusive over the more than fifteen years since the species was first described. Here, we report the discovery of a family of cyclic lipodepsipeptides that are responsible for the potent haemolytic activity of C. haemolyticum. Comparative genomics of Chromobacterium spp. isolated from different environments revealed a completely conserved gene locus ( chl ) encoding a non-ribosomal peptide synthetase (NRPS). Metabolic profiling of C. haemolyticum DSM 19808 identified a suite of cyclic lipodepsipeptides as the products of the chl locus, with the three main congeners (jagaricin, chromolysin A and B) being elucidated by a combination of tandem mass spectrometry, chemical derivatization, and NMR spectroscopy. Significantly, a C. haemolyticum chl deletion mutant is devoid of haemolytic activity. Moreover, purified jagaricin, chromolysin A and B are haemolytic at low- micromolar concentrations in an erythrocyte lysis assay. Further bioassays demonstrated that the cyclic lipodepsipeptides are crucial for biofilm-forming and swarming behavior of C. haemolyticum . MALDI mass spectrometry imaging showed that primarily chromolysin A and B are involved in these processes in vitro . Our data shed light on the bioactivities of chromolysin A and B, specialized metabolites that likely contribute to both successful colonization of new niches and virulence potential of C. haemolyticum . Importance: Despite the rising incidence of Chromobacterium haemolyticum as a serious opportunistic pathogen, there is limited information on whether the competitive traits that ensure its survival in its freshwater niche contribute to host infection. We present a case where bacterially produced specialized metabolites act as lynchpin chemical mediators that are not only responsible for the pronounced haemolytic phenotype of C. haemolyticum but are crucial for biofilm formation and swarming motility. These results exemplify a case of coincidental evolution, wherein the selective pressures encountered in a primary environmental niche drive the evolution of a trait impacting virulence. This knowledge provides a foundation for the development of antivirulence therapies against the emerging pathogen C. haemolyticum .

  • Open Access

    Transcription activator-like effectors from endosymbiotic bacteria control the reproduction of their fungal host

    by Ingrid Richter, Zerrin Uzum, Philipp Wein, Evelyn M. Molloy, Nadine Moebius, Timothy P. Stinear, Sacha J. Pidot, Christian Hertweck

    The phytopathogenic fungus Rhizopus microsporus harbors a bacterial endosymbiont ( Mycetohabitans rhizoxinica ) that produces a crucial virulence factor responsible for the characteristic symptoms of rice seedling blight. The persistence of this unique microbial alliance is ensured by evasion of fungal defense mechanisms by the resident endosymbionts and their strict control of fungal reproduction. A functional bacterial Type 3 secretion system (T3SS) is essential for the establishment of the symbiosis. Yet, the nature of the effector(s) secreted through the T3SS, and their effects on fungal physiology, has remained elusive. Using bioinformatic analysis, we identified genes encoding potential T3SS effectors, namely an alanine-tryptophan-arginine triad (AWR) peptide and a set of transcription activator-like (TAL) effectors, in the genomes of eight endofungal Mycetohabitans strains. Co-culture experiments demonstrated that the sporulating phenotype of apo-symbiotic R. microsporus is unaffected upon reinfection with M. rhizoxinica Δ awr compared to with wild-type M. rhizoxinica . In contrast, the ability of apo-symbiotic R. microsporus to produce mature sporangiophores when reinfected with M. rhizoxinica strains deficient in individual MTALs ( M. rhizoxinica Δ mtal1 , M. rhizoxinica Δ mtal2 , and M. rhizoxinica Δ mtal3 ) is significantly reduced. Trans -complementation experiments showed restoration of fungal sporulation, thus confirming that TAL effectors produced by M. rhizoxinica (MTAL1, MTAL2, and MTAL3) are needed for fungal sporulation. Using fluorescence microscopy, we show that AWR- and MTAL-deficient M. rhizoxinica strains successfully colonize apo-symbiotic R. microsporus , revealing the importance of bacterial MTALs in establishing a stable symbiosis after fungal colonization. Our findings attribute a new function to members of the MTAL family of T3SS-associated effectors and provide deeper insights into host control by prokaryotic symbionts. IMPORTANCE: Interactions between fungi and bacteria are critically important in ecology, medicine, and biotechnology. In this study, we shed light on factors that promote the persistence of a toxin-producing, phytopathogenic Rhizopus-Mycetohabitans symbiosis that causes severe crop losses in Asia. We present an unprecedented case where bacterially produced transcription activator-like (TAL) effectors are key to maintaining a stable endosymbiosis. In their absence, fungal sporulation is abrogated, leading to collapse of the phytopathogenic alliance. The Mycetohabitans TAL (MTAL)-mediated mechanism of host control illustrates a unique role of bacterial effector molecules that has broader implications, potentially serving as a model to understand how prokaryotic symbionts interact with their eukaryotic hosts.


  • Open Access

    Bacterial secretion systems contribute to rapid tissue decay in button mushroom soft rot disease

    by Philipp Wein, Katharina Dornblut, Sebastian Herkersdorf, Thomas Krüger, Evelyn M. Molloy, Axel A. Brakhage, Dirk Hoffmeister, Christian Hertweck

    The soft rot pathogen Janthinobacterium agaricidamnosum causes devastating damage to button mushrooms ( Agaricus bisporus ), one of the most cultivated and commercially relevant mushrooms. We previously discovered that this pathogen releases the membrane-disrupting lipopeptide jagaricin. This bacterial toxin, however, could not solely explain the rapid decay of mushroom fruiting bodies, indicating that J. agaricidamnosum implements a more sophisticated infection strategy. In this study, we show that secretion systems play a crucial role in soft rot disease. By mining the genome of J. agaricidamnosum , we identified gene clusters encoding a type I (T1SS), a type II (T2SS), a type III (T3SS), and two type VI secretion systems (T6SSs). We targeted the T2SS and T3SS for gene inactivation studies, and subsequent bioassays implicated both in soft rot disease. Furthermore, through a combination of comparative secretome analysis and activity-guided fractionation, we identified a number of secreted lytic enzymes responsible for mushroom damage. Our findings regarding the contribution of secretion systems to the disease process expand the current knowledge of bacterial soft rot pathogens and represent a significant stride toward identifying targets for their disarmament with secretion system inhibitors. IMPORTANCE: The button mushroom ( Agaricus bisporus ) is the most popular edible mushroom in the Western world. However, mushroom crops can fall victim to serious bacterial diseases that are a major threat to the mushroom industry, among them being soft rot disease caused by Janthinobacterium agaricidamnosum . Here, we show that the rapid dissolution of mushroom fruiting bodies after bacterial invasion is due to degradative enzymes and putative effector proteins secreted via the type II secretion system (T2SS) and the type III secretion system (T3SS), respectively. The ability to degrade mushroom tissue is significantly attenuated in secretion-deficient mutants, which establishes that secretion systems are key factors in mushroom soft rot disease. This insight is of both ecological and agricultural relevance by shedding light on the disease processes behind a pathogenic bacterial-fungal interaction which, in turn, serves as a starting point for the development of secretion system inhibitors to control disease progression.


  • Open Access

    Transcription activator-like effector protects bacterial endosymbionts from entrapment within fungal hyphae

    by Ingrid Richter, Philipp Wein, Zerrin Uzum, Claire E. Stanley, Jana Krabbe, Evelyn M. Molloy, Nadine Moebius, Iuliia Ferling, Falk Hillmann, Christian Hertweck


  • Open Access

    A Specialized Polythioamide‐Binding Protein Confers Antibiotic Self‐Resistance in Anaerobic Bacteria

    by Finn Gude, Evelyn M. Molloy, Therese Horch, Maria Dell, Kyle L. Dunbar, Jana Krabbe, Michael Groll, Christian Hertweck

    Understanding antibiotic resistance mechanisms is central to the development of anti‐infective therapies and genomics‐based drug discovery. Yet, many knowledge gaps remain regarding the resistance strategies employed against novel types of antibiotics from less‐explored producers such as anaerobic bacteria, among them the Clostridia. Through the use of genome editing and functional assays, we found that CtaZ confers self‐resistance against the copper chelator and gyrase inhibitor closthioamide (CTA) in Ruminiclostridium cellulolyticum. Bioinformatics, biochemical analyses, and X‐ray crystallography revealed CtaZ as a founding member of a new group of GyrI‐like proteins. CtaZ is unique in binding a polythioamide scaffold in a ligand‐optimized hydrophobic pocket, thereby confining CTA. By genome mining using CtaZ as a handle, we discovered previously overlooked homologs encoded by diverse members of the phylum Firmicutes, including many pathogens. In addition to characterizing both a new role for a GyrI‐like domain in self‐resistance and unprecedented thioamide binding, this work aids in uncovering related drug‐resistance mechanisms.

  • Open Access

    A Specialized Polythioamide‐Binding Protein Confers Antibiotic Self‐Resistance in Anaerobic Bacteria

    by Finn Gude, Evelyn M. Molloy, Therese Horch, Maria Dell, Kyle L. Dunbar, Jana Krabbe, Michael Groll, Christian Hertweck

    Understanding antibiotic resistance mechanisms is central to the development of anti‐infective therapies and genomics‐based drug discovery. Yet, many knowledge gaps remain regarding the resistance strategies employed against novel types of antibiotics from less‐explored producers such as anaerobic bacteria, among them the Clostridia. Through the use of genome editing and functional assays, we found that CtaZ confers self‐resistance against the copper chelator and gyrase inhibitor closthioamide (CTA) in Ruminiclostridium cellulolyticum. Bioinformatics, biochemical analyses, and X‐ray crystallography revealed CtaZ as a founding member of a new group of GyrI‐like proteins. CtaZ is unique in binding a polythioamide scaffold in a ligand‐optimized hydrophobic pocket, thereby confining CTA. By genome mining using CtaZ as a handle, we discovered previously overlooked homologs encoded by diverse members of the phylum Firmicutes, including many pathogens. In addition to characterizing both a new role for a GyrI‐like domain in self‐resistance and unprecedented thioamide binding, this work aids in uncovering related drug‐resistance mechanisms.


  • Open Access

    Alternative Benzoxazole Assembly Discovered in Anaerobic Bacteria Provides Access to Privileged Heterocyclic Scaffold

    by Therese Horch, Evelyn M. Molloy, Florian Bredy, Veit G. Haensch, Kirstin Scherlach, Kyle L. Dunbar, Jonathan Franke, Christian Hertweck

    Benzoxazole scaffolds feature prominently in diverse synthetic and natural product‐derived pharmaceuticals. Our understanding of their bacterial biosynthesis is, however, limited to ortho‐substituted heterocycles from actinomycetes. We report an overlooked biosynthetic pathway in anaerobic bacteria (typified in Clostridium cavendishii) that expands the benzoxazole chemical space to meta‐substituted heterocycles and heralds a distribution beyond Actinobacteria. The first benzoxazoles from the anaerobic realm (closoxazole A and B) were elucidated by NMR and chemical synthesis. By genome editing in the native producer, heterologous expression in Escherichia coli, and systematic pathway dissection we show that closoxazole biosynthesis invokes an unprecedented precursor usage (3‐amino‐4‐hydroxybenzoate) and manner of assembly. Synthetic utility was demonstrated by the precursor‐directed biosynthesis of a tafamidis analogue. A bioinformatic survey reveals the pervasiveness of related gene clusters in diverse bacterial phyla.